Dr. James Parker
MB ChB, FRCP, and FFPM from Glasgow and Oxford | Consultant Pharmaceutical Physician
Dr James Parker is a Consultant Pharmaceutical Physician with a specialist background in Clinical Rheumatology within the NHS. He holds an MB ChB, FRCP, and FFPM from Glasgow and Oxford. After training posts in Glasgow and Oxford, Dr. Parker entered the industry to further develop novel agents for patients with rheumatoid arthritis. During this time, he was also appointed an Honorary Consultant at Guy’s Hospital in London. Dr. Parker has held several roles as a commercially astute Medical Director in large and small pharma. He set up his own Healthcare Consultancy in 2004 and has been responsible for leading Medical Teams in the UK, Europe, Australia, and Africa. He has worked across most key therapy areas and all phases of Clinical Research, including personal responsibility for taking Byetta© (exenatide) first into man. Dr. Parker has made many contributions at the UK Board Level and, together with commercial colleagues, has been responsible for the launch of several key medicines, most recently the international launch of dolutegravir (Tivicay© and Triumeq©) with ViiV Healthcare. He is valued as a strategist, skillful facilitator, communicator, and performance enhancer. Dr Parker has an established reputation for being a serial team player, thriving on diverse inputs, and is frequently a catalyst for effective, sustainable change.